Literature DB >> 26746860

Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?

Keith Hruska1, Suresh Mathew2, Richard Lund3, Yifu Fang2, Toshifumi Sugatani2.   

Abstract

Risk factors for disease states are rigorously defined. This analysis considers the definition of a risk factor as applied to the question of whether the serum phosphorus level is a risk factor for cardiovascular disease. Observational studies strongly suggest that phosphorus is associated with cardiovascular risk, and definitive prospective animal studies are supportive. A plausible mechanism of action has been discovered demonstrating that phosphorus stimulates osteoblastic transition of cells in the neointima of atherosclerotic plaques, which, if prevented, blocks vascular calcification. However, prospective studies demonstrating that modulation of the putative risk factor affects clinical outcomes are lacking, and phosphorus, as yet, does not qualify as a cardiovascular risk factor. This is a clarion call for additional research. 0085-2538/
© 2011 The Authors. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).

Entities:  

Keywords:  arterial calcification; cardiovascular disease; mortality; phosphate

Year:  2011        PMID: 26746860     DOI: 10.1038/ki.2011.24

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Identification of differentially expressed miRNAs associated with chronic kidney disease-mineral bone disorder.

Authors:  Kyung Im Kim; Sohyun Jeong; Nayoung Han; Jung Mi Oh; Kook-Hwan Oh; In-Wha Kim
Journal:  Front Med       Date:  2017-06-14       Impact factor: 4.592

2.  Aberrant activation of Wnt pathways in arteries associates with vascular calcification in chronic kidney disease.

Authors:  Jingyi Liu; Lei Zhang; Yang Zhou; Dan Zhu; Qi Wang; Lirong Hao
Journal:  Int Urol Nephrol       Date:  2016-05-07       Impact factor: 2.370

Review 3.  Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease.

Authors:  Alessandro Caracciolo; Renato Francesco Maria Scalise; Fabrizio Ceresa; Gianluca Bagnato; Antonio Giovanni Versace; Roberto Licordari; Silvia Perfetti; Francesca Lofrumento; Natasha Irrera; Domenico Santoro; Francesco Patanè; Gianluca Di Bella; Francesco Costa; Antonio Micari
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

4.  Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.

Authors:  Yifu Fang; Charles Ginsberg; Toshifumi Sugatani; Marie-Claude Monier-Faugere; Hartmut Malluche; Keith A Hruska
Journal:  Kidney Int       Date:  2013-07-24       Impact factor: 10.612

5.  Inadequate awareness among chronic kidney disease patients regarding food and drinks containing artificially added phosphate.

Authors:  Yoshiko Shutto; Michiko Shimada; Maiko Kitajima; Hideaki Yamabe; Yoko Saitoh; Hisao Saitoh; Mohammed S Razzaque
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

6.  Critical Parameters of the In Vitro Method of Vascular Smooth Muscle Cell Calcification.

Authors:  Luis Hortells; Cecilia Sosa; Ángel Millán; Víctor Sorribas
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.